Ani pharmaceuticals, inc. completes acquisition of alimera sciences

Princeton, n.j., sept. 16, 2024 (globe newswire) -- ani pharmaceuticals, inc. (“ani” or “the company”) (nasdaq: anip) today announced the completion of its previously announced acquisition of alimera sciences, inc. (nasdaq: alim) (“alimera”).

ANIP Ratings Summary

ANIP Quant Ranking